Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
Jianxu Zhang,1,2,* Yudi Wang,2,* Jiawen Chen,2 Xiao Liang,2 Haobo Han,1,2 Yan Yang,2 Quanshun Li,1,2 Yanbo Wang1 1Department of Urology, First Hospital of Jilin University, 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University,...
Guardado en:
Autores principales: | Zhang J, Wang Y, Chen J, Liang X, Han H, Yang Y, Li Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cee84d2a3524cbe900ae36f6d0681be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017) -
D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
por: Tan X, et al.
Publicado: (2019) -
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen M, et al.
Publicado: (2019) -
Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
por: Hemati M, et al.
Publicado: (2019)